Skip to content

Preview

In focus: Semiconductor sector

The semiconductor sector remains in focus at the start of 2024, as selected stocks have rallied amid robust results and an improving outlook. The MSCI World Semiconductors and Semiconductor Equipment Index1 outperformed the global benchmark with a 9% gain in January 2024,2 following its 89% return in 2023.3 In Asia, performance was relatively mixed, but several stocks have similarly recorded sizable year-to-date gains.

We have a broadly constructive view of the semiconductor sector, where inventory issues are potentially easing and earnings growth looks set to improve over the next 12 months. However, stock selection and valuation discipline remain key, in our view.

Investment outlook

Market sentiment has improved materially. A year ago, there were significant concerns about a hard landing due to rising inflation, tightening monetary policy response and a looming energy crisis. So far in 2024, the markets have priced in a “soft-landing” scenario. Although the economy may continue to slow, any recession is likely to be mild, and it is anticipated that central banks will begin cutting interest rates by the second quarter.

At Templeton Global Equity Group, our concern is less how macro scenarios will ultimately play out, and more about the impact that different scenarios are having on individual company valuations and expectations. We continue to strive for what we view as genuinely diversified portfolios with different types of values maturing along their respective investment cycles. This focus on fundamental, bottom-up value and long-term business forecasting remains at the heart of our investment approach, and we believe it can help lead to successful client outcomes over time despite the market’s periodic knee-jerk reactions to evolving macro conditions.

Market review: January 2024

Global equities continued to rise in January 2024, but momentum has slowed compared to the fourth quarter of 2023, as waning optimism about central-bank rate cuts and mixed corporate results affected sentiment. As measured by MSCI Indexes in US-dollar terms, developed-market equities outperformed the global index, while emerging and frontier market equities trailed it. In terms of investment style, global growth stocks rose but global value stocks declined in January.

The market entered the new year with high hopes that major central banks, particularly the US Federal Reserve (Fed), might begin cutting benchmark rates soon. However, cautious messages by multiple Fed spokespersons during the month tempered that optimism. Subsequently, Fed Chair Jerome Powell ruled out a March cut after the latest policy meeting in late January, although confidence in the US inflationary and economic outlook remained high. The European Central Bank has similarly pushed back on rate cut expectations, even as the eurozone only narrowly avoided recession in the fourth quarter. Meanwhile, corporate results for the December quarter offered some signs of recovery but still largely pointed to persistent headwinds, with the blended US market earnings year-on-year growth still far below its five-year average.4



IMPORTANT LEGAL INFORMATION

Information on this website is intended to be of general information only and does not constitute investment or financial product advice. It expresses no views as to the suitability of the products or services described as to the individual circumstances, objectives, financial situation, or needs of any investor. You should conduct your own investigation or consult a financial adviser before making any decision to invest. Please read the relevant Product Disclosure Statements (PDSs), and any associated reference documents before making an investment decision.

Neither Franklin Templeton Australia, nor any other company within the Franklin Templeton group guarantees the performance of any Fund, nor do they provide any guarantee in respect of the repayment of your capital. In accordance with the Design and Distribution Obligations, we maintain Target Market Determinations (TMD) for each of our Funds. All documents can be found via the Literature Page or by calling 1800 673 776. 

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.